Blacksburg, VA, United States of America

Kuan-Fu Ding

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Introduction

Kuan-Fu Ding is a prominent inventor based in Blacksburg, Virginia, who has made significant contributions to the field of medical biotechnology. With a focus on developing innovative solutions, he holds a noteworthy patent in the area of hepatitis B vaccines.

Latest Patents

Kuan-Fu Ding's most significant patent is centered around "Hepatitis B vaccines and uses of the same." This patent features engineered hepatitis B virus (HBV) molecular vaccine constructs. Notably, these vaccine constructs can incorporate ligand-inducible engineered gene switch systems. These systems are designed to modulate the expression of heterologous genes, including cytokines, within host cells. This innovation has the potential to enhance vaccine efficacy and broaden therapeutic applications.

Career Highlights

Kuan-Fu Ding currently works at Precigen, Inc., a company dedicated to transforming the field of medicine through innovative biotherapeutics. His expertise in vaccine development has played a pivotal role in the advancement of biotechnology, positioning him as a valuable asset in the industry. Ding has proven his capability to translate complex scientific concepts into practical applications through his patented work.

Collaborations

Throughout his career, Kuan-Fu Ding has collaborated with esteemed colleagues, including Douglas E. Brough and Cheryl G. Bolinger. These partnerships have fostered a rich environment for innovation, enabling the exploration of new ideas and technologies in the fight against infectious diseases, specifically hepatitis B.

Conclusion

In summary, Kuan-Fu Ding stands out as an influential inventor in the realm of hepatitis B vaccines. His patent showcases a unique approach to vaccine design, with the potential for significant impact in the medical community. As a key player at Precigen, Inc., his contributions continue to drive advancements in biotechnology, helping to pave the way for new therapeutics and public health solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…